Healthcare provider profile · identity verified

Gerald L Wasko, MD

Family Practice · YOUNGSTOWN, OH · NPI 1265874267

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	335	95
Atorvastatin Calcium	Atorvastatin Calcium	269	74
Rosuvastatin Calcium	Rosuvastatin Calcium	224	62
Lisinopril	Lisinopril	200	59
Metoprolol Tartrate	Metoprolol Tartrate	156	44
Levothyroxine Sodium	Levothyroxine Sodium	141	44
Hydrochlorothiazide	Hydrochlorothiazide	137	40
Metoprolol Succinate	Metoprolol Succinate	135	37
Metformin Hcl	Metformin Hcl	129	35
Gabapentin	Gabapentin	119	26
Losartan Potassium	Losartan Potassium	111	31
Albuterol Sulfate Hfa	Albuterol Sulfate	105	33
Montelukast Sodium	Montelukast Sodium	98	21
Sertraline Hcl	Sertraline Hcl	98	29
Omeprazole	Omeprazole	95	29
Pantoprazole Sodium	Pantoprazole Sodium	83	24
Eliquis	Apixaban	81	19
Fluticasone Propionate	Fluticasone Propionate	76	24
Celecoxib	Celecoxib	74	21
Tamsulosin Hcl	Tamsulosin Hcl	69	27
Pregabalin	Pregabalin	66	13
Ozempic	Semaglutide	64	14
Pravastatin Sodium	Pravastatin Sodium	63	18
Ezetimibe	Ezetimibe	58	18
Glipizide	Glipizide	58	15
Allopurinol	Allopurinol	57	16
Metformin Hcl Er	Metformin Hcl	57	15
Tizanidine Hcl	Tizanidine Hcl	57	12
Tramadol Hcl	Tramadol Hcl	57	suppressed
Jardiance	Empagliflozin	56	14
Alprazolam	Alprazolam	54	11
Famotidine	Famotidine	49	15
Trulicity	Dulaglutide	47	11
Lorazepam	Lorazepam	46	11
Chlorthalidone	Chlorthalidone	44	suppressed
Furosemide	Furosemide	44	12
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Spironolactone	Spironolactone	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Meloxicam	Meloxicam	40	suppressed
Glimepiride	Glimepiride	39	12
Torsemide	Torsemide	39	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Simvastatin	Simvastatin	38	13
Synthroid	Levothyroxine Sodium	37	11
Vyvanse	Lisdexamfetamine Dimesylate	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Carvedilol	Carvedilol	35	12
Azelastine Hcl	Azelastine Hcl	34	17
Klor-Con M10	Potassium Chloride	34	suppressed
Potassium Chloride	Potassium Chloride	32	11
Tradjenta	Linagliptin	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Naproxen	Naproxen	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	12
Atenolol	Atenolol	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Diazepam	Diazepam	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Valsartan	Valsartan	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Methylprednisolone	Methylprednisolone	23	19
Mounjaro	Tirzepatide	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Creon	Lipase/Protease/Amylase	21	suppressed
Baclofen	Baclofen	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Prednisone	Prednisone	18	15
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Lidocaine	Lidocaine	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	13	suppressed
Ibu	Ibuprofen	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Kerendia	Finerenone	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error